|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/18 | (2015.01) |
| A61K 38/179 | (2013.01) | ||
| A61K 38/18 | (2006.01) | ||
| A61K 38/1816 | (2013.01) | ||
| C12Q 1/6883 | (2013.01) | ||
| A61K 35/14 | (2015.01) | ||
| C12Q2600/106 | (2013.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| C12Q2600/156 | (2013.01) | ||
| C07K 14/495 | (2006.01) | ||
| C07K 14/71 | (2013.01) | ||
| C07K 14/71 | (2006.01) | ||
| C07K 14/495 | (2013.01) | ||
| C12Q 1/6883 | (2018.01) | ||
| A61K 35/14 | (2013.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61K 35/18 | (2013.01) | ||
| A61P 7/06 | (2006.01) | ||
| C07K2319/30 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 7/06 | (2018.01) |
| (11) | Patento numeris | 3226887 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15865103.4 |
| Europos patento paraiškos padavimo data | 2015-12-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-03-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/063835 |
| Data | 2015-12-03 |
| (87) | Numeris | WO 2016/090188 |
| Data | 2016-06-09 |
| (30) | Numeris | Data | Šalis |
| 201462086977 P | 2014-12-03 | US | |
| 201462088087 P | 2014-12-05 | US | |
| 201562155395 P | 2015-04-30 | US |
| (72) |
ATTIE, Kenneth, M. , US
ROVALDI, Christopher, Robert , US
|
| (73) |
Acceleron Pharma Inc. ,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | ACTRIIB POLYPEPTIDES FOR USE IN THE TREATMENT SIDEROBLASTIC ANEMIA |
| ACTRIIB POLYPEPTIDES FOR USE IN THE TREATMENT SIDEROBLASTIC ANEMIA |